"Ishisaki A"[AU] - Search Results

Year	Number of Results
1994	1
1996	1
1997	2
1998	6
1999	3
2000	1
2001	8
2002	1
2003	6
2004	13
2005	11
2006	4
2007	1
2008	1
2009	1
2010	3
2011	6
2012	7
2013	8
2014	5
2015	4
2016	8
2017	9
2018	4
2020	4
2021	0

1

Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular-joint-derived fibroblast-like synoviocytes via mitogen-activated protein kinase kinase/extracellular signal-regulated kinase.

Matsumoto S, Yokota S, Chosa N, Kyakumoto S, Kimura H, Kamo M, Satoh K, Ishisaki A. Matsumoto S, et al. Among authors: ishisaki a. Exp Ther Med. 2020 Sep;20(3):1967-1974. doi: 10.3892/etm.2020.8944. Epub 2020 Jun 25. Exp Ther Med. 2020. PMID: 32782506 Free PMC article.

2

Dynamic polarization shifting from M1 to M2 macrophages in reduced osteonecrosis of the jaw-like lesions by cessation of anti-RANKL antibody in mice.

Tamaki S, Kuroshima S, Hayano H, Nakajima K, Kakehashi H, Ishisaki A, Sawase T. Tamaki S, et al. Among authors: ishisaki a. Bone. 2020 Dec;141:115560. doi: 10.1016/j.bone.2020.115560. Epub 2020 Jul 28. Bone. 2020. PMID: 32730924

3

TGF-β1 induces N-cadherin expression by upregulating Sox9 expression and promoting its nuclear translocation in human oral squamous cell carcinoma cells.

Hirano T, Saito D, Yamada H, Ishisaki A, Kamo M. Hirano T, et al. Among authors: ishisaki a. Oncol Lett. 2020 Jul;20(1):474-482. doi: 10.3892/ol.2020.11582. Epub 2020 May 4. Oncol Lett. 2020. PMID: 32565972 Free PMC article.

4

Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice.

Hayano H, Kuroshima S, Sasaki M, Tamaki S, Inoue M, Ishisaki A, Sawase T. Hayano H, et al. Among authors: ishisaki a. Bone. 2020 Jun;135:115308. doi: 10.1016/j.bone.2020.115308. Epub 2020 Mar 3. Bone. 2020. PMID: 32142911

5

IL‑1β and TNF‑α suppress TGF‑β‑promoted NGF expression in periodontal ligament‑derived fibroblasts through inactivation of TGF‑β‑induced Smad2/3‑ and p38 MAPK‑mediated signals.

Ohta M, Chosa N, Kyakumoto S, Yokota S, Okubo N, Nemoto A, Kamo M, Joh S, Satoh K, Ishisaki A. Ohta M, et al. Among authors: ishisaki a. Int J Mol Med. 2018 Sep;42(3):1484-1494. doi: 10.3892/ijmm.2018.3714. Epub 2018 Jun 4. Int J Mol Med. 2018. PMID: 29901090 Free PMC article.

6

Two novel mechanisms for maintenance of stemness in mesenchymal stem cells: SCRG1/BST1 axis and cell-cell adhesion through N-cadherin.

Chosa N, Ishisaki A. Chosa N, et al. Among authors: ishisaki a. Jpn Dent Sci Rev. 2018 Feb;54(1):37-44. doi: 10.1016/j.jdsr.2017.10.001. Epub 2017 Nov 9. Jpn Dent Sci Rev. 2018. PMID: 29629000 Free PMC article. Review.

7

Cell-cell interactions between monocytes/macrophages and synoviocyte-like cells promote inflammatory cell infiltration mediated by augmentation of MCP-1 production in temporomandibular joint.

Ibi M, Horie S, Kyakumoto S, Chosa N, Yoshida M, Kamo M, Ohtsuka M, Ishisaki A. Ibi M, et al. Among authors: ishisaki a. Biosci Rep. 2018 Mar 29;38(2):BSR20171217. doi: 10.1042/BSR20171217. Print 2018 Apr 27. Biosci Rep. 2018. PMID: 29535277 Free PMC article.

8

Water-soluble factors eluated from surface pre-reacted glass-ionomer filler promote osteoblastic differentiation of human mesenchymal stem cells.

Nemoto A, Chosa N, Kyakumoto S, Yokota S, Kamo M, Noda M, Ishisaki A. Nemoto A, et al. Among authors: ishisaki a. Mol Med Rep. 2018 Mar;17(3):3448-3454. doi: 10.3892/mmr.2017.8287. Epub 2017 Dec 18. Mol Med Rep. 2018. PMID: 29257332 Free PMC article.

9

Bone marrow-derived mesenchymal stem cells propagate immunosuppressive/anti-inflammatory macrophages in cell-to-cell contact-independent and -dependent manners under hypoxic culture.

Takizawa N, Okubo N, Kamo M, Chosa N, Mikami T, Suzuki K, Yokota S, Ibi M, Ohtsuka M, Taira M, Yaegashi T, Ishisaki A, Kyakumoto S. Takizawa N, et al. Among authors: ishisaki a. Exp Cell Res. 2017 Sep 15;358(2):411-420. doi: 10.1016/j.yexcr.2017.07.014. Epub 2017 Jul 14. Exp Cell Res. 2017. PMID: 28712928 Free article.

10

α2-antiplasmin modulates bone formation by negatively regulating osteoblast differentiation and function.

Kanno Y, Ishisaki A, Kuretake H, Maruyama C, Matsuda A, Matsuo O. Kanno Y, et al. Among authors: ishisaki a. Int J Mol Med. 2017 Sep;40(3):854-858. doi: 10.3892/ijmm.2017.3055. Epub 2017 Jul 5. Int J Mol Med. 2017. PMID: 28677806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results